Asset Allocation

As of November 30, 2025.
Type % Net
Cash 30.72%
Stock 46.43%
Bond 14.16%
Convertible 0.00%
Preferred 0.00%
Other 8.69%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 60.19%    % Emerging Markets: 0.00%    % Unidentified Markets: 39.81%

Americas 59.12%
59.08%
Canada 0.02%
United States 59.06%
0.04%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.02%
United Kingdom 0.20%
0.82%
France 0.00%
Ireland 0.63%
Netherlands 0.04%
Sweden 0.00%
Switzerland 0.14%
0.00%
0.00%
Saudi Arabia 0.00%
United Arab Emirates 0.00%
Greater Asia 0.05%
Japan 0.00%
0.00%
Australia 0.00%
0.05%
Singapore 0.05%
0.00%
Unidentified Region 39.81%

Bond Credit Quality Exposure

AAA 0.00%
AA 27.64%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 72.36%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
20.74%
Materials
1.29%
Consumer Discretionary
8.01%
Financials
10.04%
Real Estate
1.40%
Sensitive
43.20%
Communication Services
8.24%
Energy
2.18%
Industrials
5.97%
Information Technology
26.81%
Defensive
12.96%
Consumer Staples
3.62%
Health Care
7.51%
Utilities
1.82%
Not Classified
23.10%
Non Classified Equity
0.04%
Not Classified - Non Equity
23.06%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 99.98%
Corporate 0.02%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
92.56%
Less than 1 Year
92.56%
Intermediate
7.44%
1 to 3 Years
7.44%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial